About Artegraft
Artegraft is a company based in North Brunswick (United States) founded in 1993 was acquired by LeMaitre Vascular in June 2020.. Artegraft operates in a competitive market with competitors including Avinger, Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular and Okami Medical, among others.
- Headquarter North Brunswick, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
LeMaitre Vascular
(Jun 22, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Artegraft
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Artegraft
Artegraft has secured backing from 1 investor. Prominent investors backing the company include LeMaitre Vascular. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Devices for peripheral vascular disease treatment are developed and marketed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Artegraft
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Artegraft
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Artegraft Comparisons
Competitors of Artegraft
Artegraft operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular and Okami Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of image-guided catheter-based products for peripheral artery disease
|
|
| domain | founded_year | HQ Location |
Smart devices are provided to clear peripheral arterial blockages.
|
|
| domain | founded_year | HQ Location |
Implants for repairing arteries after angioplasty are developed.
|
|
| domain | founded_year | HQ Location |
Devices for peripheral vascular disease treatment are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Innovative medical devices for peripheral vessel treatment are developed.
|
|
| domain | founded_year | HQ Location |
Devices for removing vascular blockages are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Artegraft
When was Artegraft founded?
Artegraft was founded in 1993.
Where is Artegraft located?
Artegraft is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
Who is the current CEO of Artegraft?
Richard Gibson is the current CEO of Artegraft.
What does Artegraft do?
Artegraft was founded in 1993 and is headquartered in North Brunswick, United States. Biological bovine carotid artery grafts are offered by the company as alternatives to synthetic vascular grafts. These devices consist of a processed biological fibrous matrix designed for surgical applications in vascular procedures. Operations focus on the development and distribution of such medical implants within the healthcare sector.
Who are the top competitors of Artegraft?
Artegraft's top competitors include Avinger, Okami Medical and Cagent Vascular.
Who are Artegraft's investors?
Artegraft has 1 investor. Key investors include LeMaitre Vascular.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.